GlaxoSmithKline (GSK) reported third-quarter revenue lower than analysts forecast, as sales of blockbuster asthma drug Advair continued to fall.» Read More
Activist investor William Ackman told Allergan's board that the CEO has a 'disabling' conflict of interest because a takeover means losing his job.
AstraZeneca shares fall 13 percent after it rejects a final bid from Pfizer, calling the offer inadequate and presenting significant risks.
Chinese police have charged several former GlaxoSmithKline employees as the British drug maker is accused of evading million in Chinese taxes.
It's new, it's undoubtedly deadly. But is MERS creating too much panic? That may be the case, says one expert.
Recently released Medicare payment data is missing large amounts of information, undercutting its usefulness, the AMA said.
You just might want to pay attention to the latest health insurance jargon. It could mean thousands of dollars out of your pocket.
Some 1,400 Kaiser pharmacist may go on strike Monday, an event that could displace more than 3 million people insured by the firm—OC Register.
Veterans Affairs Secretary Eric Shinseki finds himself facing tough questions as he testifies before the Senate.
Ahead of the year's biggest event in cancer research, ASCO, research revealed AstraZeneca's cancer drug may have competition from Clovis Oncology.
The war of words over Pfizer’s attempts to take over AstraZeneca has escalated, with one politician invoking rape to describe the U.S. giant’s bids.
The U.K.'s takeover regulations should change so that the government can stop Pfizer taking over AstraZeneca if it wants to, an influential group of U.K. MPs has said.
Some stocks moved after the bell after abstracts for the American Society of Clinical Oncology meeting dropped Wednesday.
Not all protein powders or vitamins are created equal, according to San Francisco start-up LabDoor.
Three major insurers and a nonprofit group are planning to launch an online tool that will tell consumers the prices of medical procedures.
Medicaid enrollment has risen in most anti-Obamacare states, which may further strain some of their budgets.
Ian Read, chief executive of Pfizer, hit back at claims some of AstraZeneca’s drugs may be delayed if Pfizer is successful in its bid for the company.
Chinese police on Wednesday said they had charged the British former China head of drugmaker GlaxoSmithKline and other colleagues with corruption, after a 10- month probe found they paid billions of yuan in bribes to doctors and hospitals.
U.K. hearings over a potential AstraZeneca-Pfizer tie-up was a chance to discuss "Entente Cordiale" and whether leopards will change their spots.
The CEO of AstraZeneca told CNBC the U.K. pharmaceutical giant was big enough to thrive alone, but would still consider a takeover bid.
Hospital officials say one of two healthcare workers exposed to the deadly MERS virus has been hospitalized.
Get the best of CNBC in your inbox